Alexandria Real Estate Equities elects Cynthia Feldmann as independent director

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Elected March 24, 2022; term until the 2022 annual meeting.
Appointed to Science, Tech & Agtech Committee; determined independent under NYSE/SEC rules.
Received 1,000 shares of restricted stock vesting on second anniversary of grant.
Feldmann brings life science, capital markets, and public board experience; currently on boards of STERIS, UFP Tech, Frequency Therapeutics.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Cynthia L. Feldmann

director

ARE · ALEXANDRIA REAL ESTATE EQUITIES, INC.

Effective: 2022-03-24
Filed: March 25, 2022, 7:59 PM ET

On March 24, 2022, the Board of Directors (the “Board”) of Alexandria Real Estate Equities, Inc. (the “Company”) elected Cynthia L. Feldmann as a director of the Company, to serve until the 2022 annual meeting of stockholders of the Company and until her successor is duly elected and qualifies.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Cynthia L. Feldmann was elected as director at ALEXANDRIA REAL ESTATE EQUITIES, INC..

Action: elected
Role: director

Exact text from the filing

On March 24, 2022, the Board of Directors (the “Board”) of Alexandria Real Estate Equities, Inc. (the “Company”) elected Cynthia L. Feldmann as a director of the Company, to serve until the 2022 annual meeting of stockholders of the Company and until her successor is duly elected and qualifies.

View on SEC.gov

ALEXANDRIA REAL ESTATE EQUITIES, INC. filing history →

Source: SEC EDGAR

accession 0001104659-22-038078

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.